A closer look at CAR-T Cell Immunotherapy in 3D

A cinematic 3D animation showing a genetically engineered T cell recognising and destroying a cancer cell — paired with a molecular close-up of the exact receptor binding event that triggers the attack. Available to licence directly or via Science Photo Library.

 

Molecular Biology

 

A CAR-T cell crawls toward a cancer cell using amoeboid movement, makes contact, and the cancer cell shrinks and darkens as it is destroyed – visualising the mechanism behind a fast-growing area of cancer immunotherapy used to treat blood cancers including leukaemia and lymphoma.

 

 

A companion molecular close-up reveals the exact CD19 receptor binding event that triggers the attack shown above, built from real structural data (PDB entry 7URV).

 

 

Additional stills capture the cancer cell under close attack, and the CD19–CAR-T receptors locked together at the moment of binding.

 

The full CAR-T Cell series, including Left and Right camera compositions, stills, and the complete Series Pack, is available on our CAR-T Cell stock page alongside the molecular binding close-up content. For custom licensing, broadcast rights, or commission work, get in touch.